Precision health is changing the standard of care

Advancements in technology are making genomics more affordable and accessible than ever before. Likewise, societal attitudes toward genomics in clinical care are shifting. We are no longer asking ‘if’ genomics should be integrated with clinical care. Instead we are asking ‘when’ and ‘how’ we can use genomics to benefit as many people as possible.

Genomics is already saving lives and improving health outcomes and disease management for patients touched by cancer, heart disease, autism, epilepsy, rare diseases and other debilitating diseases. As genomics research moves from the bench to the bedside, clinical applications of genomics will affect many areas of medicine, improving disease prevention, diagnosis, and treatment, as well as informing our approaches to wellness, nutrition, and public health.

sector_ico_Health_trans Human Health

For most families, asthma feels like it comes out of nowhere. A child starts coughing or wheezing, and suddenly there are inhalers, doctor visits and long-term questions. Treatment...

PHOTO CREDIT: Phillip Chin
sector_ico_Health_trans Human Health

The following article was originally published by the University of British Columbia Faculty of Medicine.  For the first time, researchers at UBC have demonstrated how to reliab...

Data and Technology sector_ico_Health_trans Human Health

Because Genome BC invested in a blood-based biomarker, patients with autoimmune disease may soon get answers faster. Autoimmune diseases like rheumatoid arthritis can take years to...

PHOTO CREDIT: Gabriel Caponetti
sector_ico_Health_trans Human Health

When lymphoid cancers return after treatment, they often become more aggressive and harder to treat. Until recently, doctors had few tools to predict relapse or guide care. That’...

sector_ico_Health_trans Human Health

Led by Dr. Bruce Carleton, the GO-PGx project established a national precision medicine network with a single goal: to help children with cancer not only survive but also thrive. B...

sector_ico_Health_trans Human Health

A History of Innovation   Since our inception, Genome BC has funded crucial projects related to lymphoid cancer and our efforts continue to make a significant impact. Work in thi...

sector_ico_Health_trans Human Health

Approximately 300,000 Canadians are at high risk for hereditary cancers, making it crucial to identify these genetic changes for timely and effective intervention.  What is Heredi...

sector_ico_Health_trans Human Health

[vc_row][vc_column][vc_column_text css=""]Children should have a future, not cancer. But, just before her first birthday, Rory was fighting for her future. Born with a terat...

sector_ico_Health_trans Human Health

Understanding hereditary cancer is the difference between life and death for Chiquita Hessels. In 2011, just ten months after her mother’s death from breast cancer, and one month...

sector_ico_Health_trans Human Health

In 2002, a Technology Development platform funded by Genome BC and Genome Canada was created in BC to provide engineering support to the local life sciences research community alon...

sector_ico_Health_trans Human Health

Taylor Date’s recovery from a childhood brain tumour is a story of heroic parenting. When Taylor Date was diagnosed with medulloblastoma, a malignant cancer tumour in the bra...

sector_ico_Health_trans Human Health

A quick test would help physicians triage patients so the right people get the right treatment at the right time...

sector_ico_Health_trans Human Health

Every year, approximately 10,000 women in Canada have an amniocentesis — a prenatal procedure in which a sample of amniotic fluid is drawn by needle and tested for chromosomal ab...

sector_ico_Health_trans Human Health

The transformation of this disease from death sentence to manageable condition is one of the best- personalized medicine stories ever seen and one of the world’s best examples of...